A Study of Subcutaneously-administered Guselkumab Delivered by 3 Different Devices in Healthy Participants
Clinical trial NCT04147338 · COMPLETED
Trial details
- NCT number
- NCT04147338
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-10-30
- Primary completion
- 2021-09-13
- Enrollment
- 440
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.